Published in Nat Immunol on October 24, 2010
Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68
The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity (2012) 4.32
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A (2011) 3.53
Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity (2013) 3.51
Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol (2012) 3.43
NK cell development, homeostasis and function: parallels with CD8⁺ T cells. Nat Rev Immunol (2011) 3.38
Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38
Immunological mechanisms of vaccination. Nat Immunol (2011) 3.35
mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science (2014) 2.78
Cytokine activation induces human memory-like NK cells. Blood (2012) 2.58
Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe (2012) 2.40
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest (2013) 2.21
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun (2014) 2.06
Living in the liver: hepatic infections. Nat Rev Immunol (2012) 2.03
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med (2013) 2.02
Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A (2011) 2.01
DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol (2011) 1.98
Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med (2012) 1.89
Development, differentiation, and diversity of innate lymphoid cells. Immunity (2014) 1.87
T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med (2014) 1.82
Antigen-specific NK cell memory in rhesus macaques. Nat Immunol (2015) 1.74
B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity (2012) 1.70
Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity (2015) 1.68
IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J Exp Med (2013) 1.68
Location and cellular stages of natural killer cell development. Trends Immunol (2013) 1.59
Natural killer cells: walking three paths down memory lane. Trends Immunol (2013) 1.57
Natural killer cell biology: an update and future directions. J Allergy Clin Immunol (2013) 1.56
Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer (2015) 1.48
Organ-specific features of natural killer cells. Nat Rev Immunol (2011) 1.48
Trained immunity: A program of innate immune memory in health and disease. Science (2016) 1.43
T cell killing by tolerogenic dendritic cells protects mice from allergy. J Clin Invest (2011) 1.41
Biallelic mutations in IRF8 impair human NK cell maturation and function. J Clin Invest (2016) 1.39
Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J Immunol (2013) 1.35
IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol (2012) 1.26
Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity (2014) 1.24
Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. PLoS Pathog (2011) 1.23
Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J Exp Med (2013) 1.21
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest (2014) 1.17
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT). Immunol Rev (2014) 1.16
Immunological memory within the innate immune system. EMBO J (2014) 1.14
Emerging concepts in immunity to hepatitis C virus infection. J Clin Invest (2013) 1.12
Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep (2013) 1.12
Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol (2016) 1.12
Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Curr Opin Virol (2011) 1.09
Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc Natl Acad Sci U S A (2012) 1.08
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J Autoimmun (2015) 1.05
Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immunol (2013) 1.04
BCG-induced trained immunity in NK cells: Role for non-specific protection to infection. Clin Immunol (2014) 1.03
Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. J Immunol (2011) 1.03
Dendritic cell derived cytokines in human natural killer cell differentiation and activation. Front Immunol (2013) 1.03
Viva la revolución: rethinking influenza a virus antigenic drift. Curr Opin Virol (2011) 1.02
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci (2011) 1.02
All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends Mol Med (2011) 1.01
Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation. J Immunol (2013) 1.01
NK cells: a double-edged sword in chronic hepatitis B virus infection. Front Immunol (2013) 1.00
Understand memory, design better vaccines. Nat Immunol (2011) 1.00
Memory of infections: an emerging role for natural killer cells. PLoS Pathog (2013) 1.00
Memory NK cells: why do they reside in the liver? Cell Mol Immunol (2013) 1.00
Liver immunology. Compr Physiol (2013) 0.99
Evasion from NK cell-mediated immune responses by HIV-1. Microbes Infect (2012) 0.99
The bone marrow functions as the central site of proliferation for long-lived NK cells. J Immunol (2012) 0.97
MicroRNA function in NK-cell biology. Immunol Rev (2013) 0.96
NK cells: immune cross-talk and therapeutic implications. Immunotherapy (2011) 0.96
Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines. Pediatr Res (2013) 0.96
Activation of natural killer cells during microbial infections. Front Immunol (2012) 0.96
Natural Killer Cells in Viral Hepatitis. Cell Mol Gastroenterol Hepatol (2015) 0.96
Natural Killer Cell Memory. Immunity (2015) 0.96
Natural killer cells: multifaceted players with key roles in hepatitis C immunity. Immunol Rev (2013) 0.95
Host genes important to HIV replication and evolution. Cold Spring Harb Perspect Med (2012) 0.95
A distinct subpopulation of human NK cells restricts B cell transformation by EBV. J Immunol (2013) 0.95
CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver. Sci Rep (2016) 0.93
Subsets of human natural killer cells and their regulatory effects. Immunology (2014) 0.93
Natural killer cells: from basic research to treatments. Front Immunol (2011) 0.93
Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. J Exp Med (2014) 0.92
Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection. J Exp Med (2014) 0.92
Emerging insights into natural killer cells in human peripheral tissues. Nat Rev Immunol (2016) 0.91
Comparing the kinetics of NK cells, CD4, and CD8 T cells in murine cytomegalovirus infection. J Immunol (2011) 0.91
No monkey business: why studying NK cells in non-human primates pays off. Front Immunol (2013) 0.91
Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response. Front Immunol (2011) 0.90
Natural killer cells in non-hematopoietic malignancies. Front Immunol (2012) 0.89
SHIP1 intrinsically regulates NK cell signaling and education, resulting in tolerance of an MHC class I-mismatched bone marrow graft in mice. J Immunol (2015) 0.89
The aryl hydrocarbon receptor promotes IL-10 production by NK cells. J Immunol (2014) 0.89
Human Cytokine-Induced Memory-Like Natural Killer Cells. J Innate Immun (2015) 0.89
Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV. Front Immunol (2014) 0.89
Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12. Immunology (2013) 0.89
Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations. Front Immunol (2016) 0.89
Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cells. PLoS One (2013) 0.88
Liver natural killer cells: subsets and roles in liver immunity. Cell Mol Immunol (2015) 0.88
Evidence for natural killer cell memory. Curr Biol (2013) 0.88
Natural killer cell regulation - beyond the receptors. F1000Prime Rep (2014) 0.88
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control. World J Gastroenterol (2015) 0.87
Natural killer cells regulate T cell immune responses in primary biliary cirrhosis. Hepatology (2015) 0.86
Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation. J Exp Med (2014) 0.86
In vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infection. PLoS Pathog (2014) 0.85
Natural killer cells as helper cells in dendritic cell cancer vaccines. Front Immunol (2015) 0.84
Natural Killer Cells and Liver Fibrosis. Front Immunol (2016) 0.84
The impact of Ly49-NK cell-dependent recognition of MCMV infection on innate and adaptive immune responses. J Biomed Biotechnol (2011) 0.84
More things in heaven and earth: defining innate and adaptive immunity. Nat Immunol (2010) 0.84
NK cell recognition. Annu Rev Immunol (2005) 14.40
Adaptive immune features of natural killer cells. Nature (2009) 8.46
Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol (2008) 7.88
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58
Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 7.40
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity (1995) 7.08
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
The mechanism and regulation of chromosomal V(D)J recombination. Cell (2002) 6.28
T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol (2006) 6.23
Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 5.17
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1995) 5.06
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol (2006) 5.00
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature (2001) 4.76
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med (2007) 4.14
Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol (2005) 4.01
A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol (2000) 3.44
Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol (2006) 3.04
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol (2007) 2.71
Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol (2001) 2.12
Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today (1999) 2.08
Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J Immunol (2004) 2.07
Relationship between CD107a expression and cytotoxic activity. Cell Immunol (2008) 1.95
NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol (2007) 1.78
NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol (2000) 1.70
Natural killer cell tolerance licensing and other mechanisms. Adv Immunol (2009) 1.60
Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver. J Immunol (2005) 1.48
Influenza vaccines based on virus-like particles. Virus Res (2009) 1.48
Adaptive immune responses mediated by natural killer cells. Immunol Rev (2010) 1.48
Stress-induced enhancement of skin immune function: A role for gamma interferon. Proc Natl Acad Sci U S A (2000) 1.39
Evidence for NK cell subsets based on chemokine receptor expression. J Immunol (2006) 1.39
Delayed hypersensitivity in mice; its detection by skin tests and its passive transfer. Science (1959) 1.33
Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles. J Virol (2007) 1.25
Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis (2010) 1.16
B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J Immunol (2003) 1.15
Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. J Invest Dermatol (2007) 1.13
Immunology. A sense of something missing. Nature (1992) 1.13
Natural killer and T cells of innate and adaptive immunity: lymphoid compartments with different requirements for common gamma chain-dependent cytokines. Immunol Rev (1998) 1.07
Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na). J Immunol (1974) 1.04
Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations. Blood (2007) 1.02
NK gene complex haplotype variability and host resistance alleles to murine cytomegalovirus in wild mouse populations. Immunol Cell Biol (2005) 1.00
Drug-protein conjugates--XI. Disposition and immunogenicity of dinitrofluorobenzene, a model compound for the investigation of drugs as haptens. Biochem Pharmacol (1987) 0.95
An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells. J Leukoc Biol (2010) 0.95
CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses. J Immunol (2009) 0.91
A novel method for isolation of human lung T cells from lung resection tissue reveals increased expression of GAPDH and CXCR6. J Immunol Methods (2009) 0.90
Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose? Exp Dermatol (2005) 0.87
Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol (2003) 15.51
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 10.58
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA (2010) 9.26
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA (2012) 8.94
Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol (2003) 7.89
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology (2010) 7.86
Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol (2005) 7.47
WGAViewer: software for genomic annotation of whole genome association studies. Genome Res (2008) 7.15
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol (2006) 6.23
Towards an HIV cure: a global scientific strategy. Nat Rev Immunol (2012) 5.52
Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol (2008) 5.37
Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science (2006) 5.31
Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell (2007) 5.17
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature (2007) 4.88
T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat Immunol (2008) 4.52
Dynamic visualization of thrombopoiesis within bone marrow. Science (2007) 4.35
Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity (2006) 3.92
Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature (2010) 3.71
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
Gain-of-function experiments on H7N9. Science (2013) 3.67
HIV-infected T cells are migratory vehicles for viral dissemination. Nature (2012) 3.57
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med (2003) 3.41
Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity (2005) 3.39
Intravital microscopy: visualizing immunity in context. Immunity (2004) 3.37
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet (2002) 3.32
Dissolving polymer microneedle patches for influenza vaccination. Nat Med (2010) 3.24
Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol (2005) 3.07
Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity (2007) 3.07
Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol (2009) 3.05
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J Exp Med (2005) 3.02
Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity (2009) 2.98
T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol (2006) 2.94
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenet Genomics (2005) 2.94
Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol (2009) 2.84
CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med (2007) 2.81
Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol (2006) 2.73
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol (2007) 2.71
Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med (2006) 2.69
Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe (2012) 2.66
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. J Infect Dis (2005) 2.58
Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med (2006) 2.43
Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nat Immunol (2007) 2.41
Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature (2011) 2.36
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
The clearance mechanism of chilled blood platelets. Cell (2003) 2.25
Mechanisms and consequences of dendritic cell migration. Immunity (2008) 2.25
Pause on avian flu transmission research. Science (2012) 2.24
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood (2013) 2.18
Stem cell trafficking in tissue development, growth, and disease. Cell (2008) 2.15
In vivo imaging of lymphocyte trafficking. Annu Rev Cell Dev Biol (2005) 2.15
How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol (2010) 2.11
In vivo imaging of leukocyte trafficking in blood vessels and tissues. Curr Opin Immunol (2004) 2.10
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol (2007) 2.09
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus. PLoS Pathog (2012) 2.09
Transdermal delivery of insulin using microneedles in vivo. Pharm Res (2004) 2.07
Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol (2007) 2.06
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection. Clin Pharmacol Ther (2003) 2.05
Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol (2006) 2.05
Update of the drug resistance mutations in HIV-1: Fall 2005. Top HIV Med (2005) 2.04
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol (2012) 2.03
Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization. Nat Cell Biol (2007) 2.01
Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity (2010) 2.00
Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction. Immunity (2004) 1.98
Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential. Nat Immunol (2003) 1.97
APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol (2004) 1.97
Natural killer cell memory. Nat Immunol (2011) 1.96
Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One (2009) 1.95
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet (2003) 1.94
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. J Infect Dis (2005) 1.93
Alpha4 integrins as therapeutic targets in autoimmune disease. N Engl J Med (2003) 1.90
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog (2010) 1.90
Immune regulation of multiple sclerosis by transdermally applied myelin peptides. Ann Neurol (2010) 1.89
24 hours in the life of HIV-1 in a T cell line. PLoS Pathog (2013) 1.89
A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat Immunol (2005) 1.89
Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol (2003) 1.87
Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol (2003) 1.86
CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity (2012) 1.85
Update of the Drug Resistance Mutations in HIV-1: 2005. Top HIV Med (2005) 1.83
Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice. Blood (2011) 1.83
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A (2009) 1.82
Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS (2006) 1.81
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Arch Intern Med (2007) 1.80
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenet Genomics (2009) 1.79
Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One (2009) 1.78
Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A (2008) 1.77